ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

NSCI Netscientific Plc

63.00
0.00 (0.00%)
Last Updated: 07:47:54
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Netscientific Plc LSE:NSCI London Ordinary Share GB00BN4R5Q82 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 63.00 61.00 65.00 63.00 63.00 63.00 1,474 07:47:54
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 1M -3.09M -0.1312 -4.80 14.85M
Netscientific Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker NSCI. The last closing price for Netscientific was 63p. Over the last year, Netscientific shares have traded in a share price range of 49.00p to 80.50p.

Netscientific currently has 23,574,303 shares in issue. The market capitalisation of Netscientific is £14.85 million. Netscientific has a price to earnings ratio (PE ratio) of -4.80.

Netscientific Share Discussion Threads

Showing 626 to 649 of 5750 messages
Chat Pages: Latest  26  25  24  23  22  21  20  19  18  17  16  15  Older
DateSubjectAuthorDiscuss
07/3/2017
08:28
Yasmin - all you have done here is shown yourself to be no better than the ramping halfwits you see on other threads.Good luck with this "investment". Looks more likely to see 30p than a quid.
beeks of arabia
07/3/2017
08:14
selling @55p now....
runwaypaul
28/2/2017
13:00
Heading to 40p sometime imo.
blueball
28/2/2017
09:56
Escape,
I thought the bottom had been called here:

"yasX 16 Feb '17 - 01:37 - 632 of 641 1 0

Meanwhile NSCI holding firm the past few days - looks like Chewin was advising selling yet another stock at the very bottom. He really is a perfect contrarian signal."


Anyone investing here must be looking years out, the money is dead right now, who would buy a chart like that until there is a turnaround - go where the money is (e.g the market is keen on TRIN ).

che7win
27/2/2017
21:57
An unacceptable share price performance.

Come on Netscientific , lets do the jiggle jiggle!

escapetohome
27/2/2017
14:22
Where have all the buyers gone.
blueball
22/2/2017
14:53
Yep, that's the long and short of your contributions.

Yas - It would be good to get some further guidance on this one. When do you think this will add to the bottom line and are they more likely to sell before that point?

beeks of arabia
22/2/2017
14:46
zzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzz...............................
runwaypaul
22/2/2017
10:40
Needs volume.
beeks of arabia
22/2/2017
08:58
22 February 2017

NetScientific plc

("NetScientific" or the "Company" or the "Group")

Vortex Biosciences Announces Commercial Launch of Fully Automated Liquid Biopsy System for

CTC Isolation

London, UK - 22 February 2017 - NetScientific plc (AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces that its portfolio company, Vortex Biosciences, has begun the commercial launch of the VTX1 Liquid Biopsy System; its fully automated benchtop system for collecting intact circulating tumour cells (CTCs) that are shed by tumours, using patented innovative microfluidic technology.

NetScientific shareholding in Vortex is 95% and as of 31 December 2016, the Group has invested GBP13.1 million. Grant funding received to develop the underlying technology, prior to Vortex's formation, was GBP1.6 million.

Commenting on the news, François R. Martelet, Chief Executive Officer of NetScientific, said: "We are pleased to announce the commercial launch of Vortex's VTX-1 Liquid Biopsy System into research labs. We believe the technology has several key advantages over current approaches to CTC isolation and has the potential to make a meaningful impact on cancer research and assist the development of innovative diagnostics and therapeutics. The commercial launch is a critical milestone for Vortex and brings our portfolio company closer to significant value creation."

escapetohome
22/2/2017
08:06
Great news!
yasx
16/2/2017
12:29
However i bet my dad can fight your dad!Pathetic. Give it a rest you two.
beeks of arabia
16/2/2017
12:28
Oh really?
No doubt you know, as I posted nearly all my trades from August last year to December as they happened on advfn - they are there for all to see - posted upfront - so you can see where and how I made profits.

I'm contrarian, unlike you who follows Zengas, I call it out the way I see it.

I'm honest enough to say when I make mistakes, you of course never make mistakes.

BTW, I don't recall ever calling this out as a sell as I'm not qualified to give financial advice - if I did however, it might have saved horrendous losses for some.

che7win
16/2/2017
01:37
Meanwhile NSCI holding firm the past few days - looks like Chewin was advising selling yet another stock at the very bottom. He really is a perfect contrarian signal.
yasx
16/2/2017
01:36
Well, funny you mention Zengas - I have never followed him into anything. Indeed, why don't you ask Zengas what I told him about TRIN at 2p last summer and why he should be buying. I do not publish confidential messages, but, if he wishes to clarify he can do so. Indeed, he reminded me recently in a private message that it was a tremendous call, and I again at 8p told him that we were still at the foothills. He agreed, and though he will surely assess things for himself rather than rely on me, he will confirm I put Trinity to him not the other way around.

As for HNR, again I was the first to spot the potential for price appreciation - but, I very early realised it was not quite what it purported to be and sold banking a good gain - it carried on much higher, but I buy value, not speculative price spikes.

Off you go - select some of your own picks and stop this obsession with this gracious chap. You see, you need to read my thoughts, not vice versa. Some lead, others follow. Hope that helps.

yasx
15/2/2017
19:58
Oh dear, I'm doing very well thank you. We all know you follow Zengas around. You followed him into HNR at 20p, sold out too early and watched it quadruple - with you left behind.
che7win
15/2/2017
19:05
Chewin simply follows me around - it is no coincidence that wherever I appear, he follows. I took Trinity just prior to suspension and since resumption of trading have been shouting from the rooftops about the undervaluation, taking yet more still at just over 6p. Coincidentally, Chewin is now a fan of that too. I have produced detailed analysis on it applauded by many readers, whereas this nut has done no analysis other than declaring some curved bottom or just buying because I have.

His top pick for the decade was Iofina at 200p, on which he placed a £150 target. I jest not. Oh dear.

What a hopeless plum.

yasx
15/2/2017
10:39
There we go, Trin just moved up 10%
che7win
15/2/2017
09:58
Escape,

Sellers have readily been able to get 60p for days even with the spread noted as 58-63p. But, try buying a significant line.... one will likely have to pay at least 70p.

yasx
15/2/2017
09:57
Escape, Would you not be better buying TRIN?
che7win
15/2/2017
08:58
Yes, 6% spread immediately you buy.
che7win
15/2/2017
08:38
Had a top up but it cost me , 63.5 p or something like that , where the bid was much lower.
escapetohome
15/2/2017
07:17
A prestigious award, great recognition chaps.
che7win
13/2/2017
12:30
che7win

little heads up

runawaypaul/loveandmoney1/purple11 are all the same person. Paul tends to use all
three when on a pump and dump mission.

tradermick1
Chat Pages: Latest  26  25  24  23  22  21  20  19  18  17  16  15  Older

Your Recent History

Delayed Upgrade Clock